Active, not recruitingPhase 2NCT04517214

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fudan University
Principal Investigator
Chaosu Hu, M.D.
Fudan University
Intervention
Toripalimab(drug)
Enrollment
100 target
Eligibility
18-70 years · All sexes
Timeline
2020 – 2026

Study locations (1)

Collaborators

Fudan University Eye and ENT Hospital · Anhui Provincial Hospital · Sir Run Run Shaw Hospital · Hangzhou Cancer Hospital · Ningbo Medical Center Lihuili Hospital · The First People's Hospital of Changzhou · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center · Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Nanfang Hospital, Southern Medical University · Shenzhen People's Hospital · First Affiliated Hospital of Xi'anJiaotong Univerisity · Guangzhou Panyu Central Hospital · Fujian Cancer Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04517214 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma →

← Back to all trials